These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23317632)

  • 21. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study.
    Cook D; Laporta D; Skrobik Y; Peters S; Sharpe M; Murphy P; Chin D; Crowther M;
    J Crit Care; 2001 Dec; 16(4):161-6. PubMed ID: 11815901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.
    Tincani E; Mannucci C; Casolari B; Turrini F; Crowther MA; Prisco D; Cenci AM; Bondi M
    Haematologica; 2006 Jul; 91(7):976-9. PubMed ID: 16757417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
    Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
    J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges.
    Heddle NM; Wu C; Vassallo R; Carey P; Arnold D; Lozano M; Pavenski K; Sweeney J; Stanworth S; Liu Y; Traore A; Barty R; Tinmouth A;
    Transfusion; 2011 Nov; 51(11):2304-10. PubMed ID: 21599672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjudication of a primary trial outcome: Results of a calibration exercise and protocol for a large international trial.
    Cook D; Deane A; Dionne JC; Lauzier F; Marshall JC; Arabi YM; Wilcox ME; Ostermann M; Al-Fares A; Heels-Ansdell D; Zytaruk N; Thabane L; Finfer S;
    Contemp Clin Trials Commun; 2024 Jun; 39():101284. PubMed ID: 38559746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
    Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
    J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.
    Nurmohamed MT; van Riel AM; Henkens CM; Koopman MM; Que GT; d'Azemar P; Büller HR; ten Cate JW; Hoek JA; van der Meer J; van der Heul C; Turpie AG; Haley S; Sicurella A; Gent M
    Thromb Haemost; 1996 Feb; 75(2):233-8. PubMed ID: 8815566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism in critical illness in a community intensive care unit.
    Muscedere JG; Heyland DK; Cook D
    J Crit Care; 2007 Dec; 22(4):285-9. PubMed ID: 18086398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dalteparin: new indication. Prophylaxis in medical patients: no advance.
    Prescrire Int; 2005 Feb; 14(75):14-5. PubMed ID: 15751168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.
    Lederle FA; Zylla D; MacDonald R; Wilt TJ
    Ann Intern Med; 2011 Nov; 155(9):602-15. PubMed ID: 22041949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring clinical bleeding using a standardized daily report form and a computer algorithm for adjudication of WHO bleeding grades.
    Middelburg RA; Ypma PF; van der Meer PF; van Wordragen-Vlaswinkel RJ; Eissen O; Kerkhoffs JL
    Vox Sang; 2013 Aug; 105(2):144-9. PubMed ID: 23517250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.
    Harper C; Mafham M; Herrington W; Staplin N; Stevens W; Wallendszus K; Haynes R; Landray MJ; Parish S; Bowman L; Armitage J
    Heart; 2023 Sep; 109(19):1467-1472. PubMed ID: 37270201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
    Godolphin PJ; Montgomery AA; Woodhouse LJ; Bereczki D; Berge E; Collins R; Díez-Tejedor E; Gommans J; Lees KR; Ozturk S; Phillips S; Pocock S; Prasad K; Szatmari S; Wang Y; Bath PM; Sprigg N;
    PLoS One; 2018; 13(11):e0208142. PubMed ID: 30475912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.